p-hydroxyamphetamine has been researched along with Urinary Bladder, Overactive in 3 studies
p-Hydroxyamphetamine: Amphetamine metabolite with sympathomimetic effects. It is sometimes called alpha-methyltyramine, which may also refer to the meta isomer, gepefrine.
Urinary Bladder, Overactive: Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.
Excerpt | Relevance | Reference |
---|---|---|
" The bioavailability of KUC-7322 was estimated to be 4%." | 1.40 | Absorption, disposition, metabolism, and excretion of ritobegron (KUC-7483), a novel selective β3-adrenoceptor agonist, in rats. ( Abe, Y; Endo, T; Kobayashi, M; Murakami, M; Ota, E, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, Y | 1 |
Ota, E | 1 |
Endo, T | 1 |
Murakami, M | 1 |
Kobayashi, M | 1 |
Maruyama, I | 2 |
Tatemichi, S | 2 |
Goi, Y | 2 |
Maruyama, K | 2 |
Hoyano, Y | 2 |
Yamazaki, Y | 2 |
Kusama, H | 2 |
3 other studies available for p-hydroxyamphetamine and Urinary Bladder, Overactive
Article | Year |
---|---|
Absorption, disposition, metabolism, and excretion of ritobegron (KUC-7483), a novel selective β3-adrenoceptor agonist, in rats.
Topics: Acetates; Adrenergic beta-3 Receptor Agonists; Animals; Area Under Curve; Bile; Biotransformation; F | 2014 |
Effects of ritobegron (KUC-7483), a novel selective β3-adrenoceptor agonist, on bladder function in cynomolgus monkey.
Topics: Acetates; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Animals; Bloo | 2012 |
Bladder selectivity of the novel β₃-agonist ritobegron (KUC-7483) explored by in vitro and in vivo studies in the rat.
Topics: Acetates; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic be | 2012 |